US 11370827
Chimeric factor VIII polypeptides and uses thereof
granted A61KA61K38/37A61K47/62
Quick answer
US patent 11370827 (Chimeric factor VIII polypeptides and uses thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61K, A61K38/37, A61K47/62, A61P, A61P7/04